Administrative Office; C621 GH
PRMC Chair: Roger Gingrich, MD, PhD
Associate Director for Quality
Holden Comprehensive Cancer Center
Director, Adult Blood & Marrow Transplantation Program
Director, Hematology and Medical Oncology Fellowship Program
Professor, Internal Medicine
Ph: 319-356-3425
roger-gingrich@uiowa.edu
PRMC Co-Chair: C. Michael Knudson, MD, PhD
Associate Professor, Transfusion Medicine
Director, Medical Scientist Training Program
Ph: 319-335-8147
c-knudson@uiowa.edu
Protocol Administrator: Gary Rick, MSW
Location: C621 GH
Ph: 319-353-7846
Fax: 319-356-0471
gary-rick@uiowa.edu
PRMC Biostatisticians
Brian Smith, PhD
Phone: 319-384-5026
brian-j-smith@uiowa.edu
Gideon Zamba, PhD
Phone: 319-384-5020
gideon-zamba@uiowa.edu
All cancer clinical trials at the Holden Comprehensive Cancer Center at The University of Iowa are reviewed by the Protocol Review and Monitoring Committee (PRMC). No protocol may have access to Cancer Center shared resources without full approval of the committee. All cancer intramural studies, industry trials, or cooperative group studies are required to be sanctioned by the PRMC.
The purpose of the review is:
- To conduct a scientific review of all proposed and ongoing institutional cancer clinical research
- To monitor all clinical cancer research protocols for sufficient progress
- To determinate those cancer protocols that are not achieving goals in a reasonable time frame
- To determine prioritization of patient referrals to competing protocols or if you have any questions regarding the Committee, please contact Gary Rick, Protocol Administrator, 319-353-7846.
To ensure efficient use of Cancer Center resources for clinical trials, all protocols submitted to the PRMC must also be reviewed and approved by the appropriate Multidisciplinary Oncology Group (MOG). This review may occur before, or in parallel with the PRMC review. However, final approval by the PRMC will be contingent upon approval by the MOG (
MOGs and Clinical Liaisons). To verify approval, the following form should be completed and submitted to the PRMC:
Multidisciplinary Oncology Group Clinical Trial Checklist (MS Word Format)
Protocol Submission Form (MS Word Format)
G-12 New Drug Data Template--v12-18-07
G-12 Completion Guidelines
PRMC Members
- Chair: Roger Gingrich, MD, PhD, Associate Director for Quality, Holden Comprehensive Cancer Center; Professor, Internal Medicine
- Co-Chair: C. Michael Knudson, MD, PhD, Associate Professor, Transfusion Medicine, Director, Medical Scientist Training Program
- Douglas Van Daele, MD, Assistant Professor, Department of Otolaryngology—Head and Neck Surgery
- Daryl J. Murry, Pharm.D., Associate Professor, College of Pharmacy
- Mark K. Sorenson, Pharm.D., Clinical Pharmacy Specialist, College of Pharmacy
- Natalie L. Denburg, PhD, Assistant Professor, Neurology and Neuroscience
- Yusuf Menda, MD, Assistant Professor, Radiology-Nuclear Medicine
- Brian J. Smith, PhD, Assistant Professor, Biostatistics
- Anjali Gupta, MD, Associate Professor, Radiation Oncology
- Michael Goodheart, MD, Associate Professor, Obstetrics and Gynecology
- Mohammed Milhem, MB, BS, Clinical Assistant Professor, Internal Medicine, Hematology, Oncology and Blood & Marrow Transplantation
- Nelson Yee, MD, PhD, RPh, Assistant Professor, Internal Medicine, Hematology, Oncology and Blood &
Marrow Transplantation
- Lori Rosenstein, MD, Hematology, Oncology and Blood & Marrow Transplantation
- George Weiner, MD, Director, Holden Comprehensive Cancer Center; Professor, Internal Medicine
- Gideon J. Zamba, PhD, Assistant Professor, Biostatistics
- Gary A. Rick, MSW, Protocol Administrator
|
|
